United States · FDA National Drug Code directory
Spravato
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50458-028_309ff0be-81dc-4e85-9fe3-937e88e44e6e
- Product NDC
- 50458-028
- Form
- SOLUTION
- Composition / generic term
- Esketamine Hydrochloride
- Labeler
- Janssen Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190305
- Source listing expiry
- 20271231
Source-listed ingredients
- ESKETAMINE HYDROCHLORIDE — 28 mg/.2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BLISTER PACK in 1 KIT (50458-028-02) / 1 VIAL, SINGLE-USE in 1 BLISTER PACK / .2 mL in 1 VIAL, SINGLE-USE (50458-028-00) · 50458-028-02
- 3 BLISTER PACK in 1 KIT (50458-028-03) / 1 VIAL, SINGLE-USE in 1 BLISTER PACK / .2 mL in 1 VIAL, SINGLE-USE (50458-028-00) · 50458-028-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →